129 related articles for article (PubMed ID: 1314999)
1. Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients.
al-Khursany I; Thomas TH; Harrison K; Wilkinson R
Nephrol Dial Transplant; 1992; 7(3):251-5. PubMed ID: 1314999
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin-induced renal magnesium leak in renal transplant patients.
Scoble JE; Freestone A; Varghese Z; Fernando ON; Sweny P; Moorhead JF
Nephrol Dial Transplant; 1990; 5(9):812-5. PubMed ID: 2129356
[TBL] [Abstract][Full Text] [Related]
3. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
[TBL] [Abstract][Full Text] [Related]
4. Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporin.
Haag-Weber M; Schollmeyer P; Hörl WH
Miner Electrolyte Metab; 1990; 16(1):66-8. PubMed ID: 2325594
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients.
Frost L; Danielsen H; Dørup I; Kjaer T; Pedersen EB
Nephrol Dial Transplant; 1993; 8(1):79-83. PubMed ID: 8381943
[TBL] [Abstract][Full Text] [Related]
6. Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine.
Gordjani N; Offner G; Hoyer PF; Brodehl J
Arch Dis Child; 1990 Mar; 65(3):275-9. PubMed ID: 2334203
[TBL] [Abstract][Full Text] [Related]
7. Increased erythrocyte magnesium content in essential hypertension.
Kjeldsen SE; Sejersted OM; Frederichsen P; Leren P; Eide IK
Scand J Clin Lab Invest; 1990 Jun; 50(4):395-400. PubMed ID: 2392652
[TBL] [Abstract][Full Text] [Related]
8. Magnesium status and excretion in age-matched subjects with normal and elevated blood pressures.
Fischer PW; Belonje B; Giroux A
Clin Biochem; 1993 Jun; 26(3):207-11. PubMed ID: 8330390
[TBL] [Abstract][Full Text] [Related]
9. Magnesium in cyclosporin-treated kidney transplant patients.
Kaiser W
Nephrol Dial Transplant; 1991; 6(5):374. PubMed ID: 1870756
[No Abstract] [Full Text] [Related]
10. Increased erythrocyte magnesium in untreated essential hypertension.
Kjeldsen SE; Sejersted OM; Frederichsen P; Leren P; Eide IK
J Hypertens Suppl; 1989 Dec; 7(6):S156-7. PubMed ID: 2632702
[TBL] [Abstract][Full Text] [Related]
11. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
Markell MS; Altura BT; Barbour RL; Altura BM
Clin Sci (Lond); 1993 Sep; 85(3):315-8. PubMed ID: 8403804
[TBL] [Abstract][Full Text] [Related]
12. Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.
Corica F; Ientile R; Allegra A; Romano G; Cangemi F; Di Benedetto A; Buemi M; Cucinotta D; Ceruso D
Biol Trace Elem Res; 1996 Jan; 51(1):13-21. PubMed ID: 8834376
[TBL] [Abstract][Full Text] [Related]
13. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
Hamilton DV; Carmichael DJ; Evans DB; Calne RY
Transplant Proc; 1982 Sep; 14(3):597-600. PubMed ID: 6758243
[No Abstract] [Full Text] [Related]
14. Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension.
Paolisso G; Passariello N; Sgambato S; Torecca R; Buoninconti R; Varricchio M; D'Onofrio F
Clin Sci (Lond); 1987 Nov; 73(5):535-9. PubMed ID: 3315399
[TBL] [Abstract][Full Text] [Related]
15. Intralymphocyte free magnesium in a group of subjects with essential hypertension.
Delva PT; Pastori C; Degan M; Montesi GD; Lechi A
Hypertension; 1996 Sep; 28(3):433-9. PubMed ID: 8794829
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin-induced hypomagnesaemia and renal magnesium wasting in rats.
Wong NL; Dirks JH
Clin Sci (Lond); 1988 Nov; 75(5):509-14. PubMed ID: 3254764
[TBL] [Abstract][Full Text] [Related]
17. Systemic magnesium deficiency disclosed by magnesium loading test in patients with essential hypertension.
Ozono R; Oshima T; Matsuura H; Higashi Y; Ishida T; Watanabe M; Yoshimura M; Hiraga H; Ono N; Kajiyama G
Hypertens Res; 1995 Mar; 18(1):39-42. PubMed ID: 7584908
[TBL] [Abstract][Full Text] [Related]
18. Renal handling of magnesium in transplanted children under cyclosporin A treatment.
Krull F; Hoyer PF; Offner G; Brodehl J
Eur J Pediatr; 1988 Nov; 148(2):148-51. PubMed ID: 3069471
[TBL] [Abstract][Full Text] [Related]
19. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation.
Thompson ME; Shapiro AP; Johnsen AM; Itzkoff JM; Hardesty RL; Griffith BP; Bahnson HT; McDonald RH; Hastillo A; Hess M
Int J Cardiol; 1986 May; 11(2):219-29. PubMed ID: 3519476
[TBL] [Abstract][Full Text] [Related]
20. Magnesium after renal transplantation--comparison between cyclosporine A and conventional immunosuppression.
Kaiser W; Biesenbach G; Kramer E; Zazgornik J
Adv Exp Med Biol; 1989; 252():297-302. PubMed ID: 2675555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
